Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 24;5(1):e5.
doi: 10.2196/rehab.7805.

The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review

Affiliations

The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review

Martin Marziniak et al. JMIR Rehabil Assist Technol. .

Abstract

Despite recent advances in multiple sclerosis (MS) care, many patients only infrequently access health care services, or are unable to access them easily, for reasons such as mobility restrictions, travel costs, consultation and treatment time constraints, and a lack of locally available MS expert services. Advances in mobile communications have led to the introduction of electronic health (eHealth) technologies, which are helping to improve both access to and the quality of health care services. As the Internet is now readily accessible through smart mobile devices, most people can take advantage of eHealth apps. The development of digital applications and remote communication technologies for patients with MS has increased rapidly in recent years. These apps are intended to complement traditional in-clinic approaches and can bring significant benefits to both patients with MS and health care providers (HCPs). For patients, such eHealth apps have been shown to improve outcomes and increase access to care, disease information, and support. These apps also help patients to participate actively in self-management, for example, by tracking adherence to treatment, changes in bladder and bowel habits, and activity and mood. For HCPs, MS eHealth solutions can simplify the multidisciplinary approaches needed to tailor MS management strategies to individual patients; facilitate remote monitoring of patient symptoms, adverse events, and outcomes; enable the efficient use of limited resources and clinic time; and potentially allow more timely intervention than is possible with scheduled face-to-face visits. These benefits are important because MS is a long-term, multifaceted chronic condition that requires ongoing monitoring, assessment, and management. We identified in the literature 28 eHealth solutions for patients with MS that fall within the four categories of screening and assessment, disease monitoring and self-management, treatment and rehabilitation, and advice and education. We review each solution, focusing on any clinical evidence supporting their use from prospective trials (including ASSESS MS, Deprexis, MSdialog, and the Multiple Sclerosis Performance Test) and consider the opportunities, barriers to adoption, and potential pitfalls of eHealth technologies in routine health care.

Keywords: communication; eHealth; multiple sclerosis; technology; telehealth; telemedicine; telerehabilitation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: MM has received lecture fees, travel grants, and fees for consulting from Bayer HealthCare AG, Beiersdorf AG, Biogen Idec GmbH, Merck KGaA, Novartis Pharma GmbH, Pfizer Pharma GmbH, Sanofi-Aventis (Genzyme), and Teva. GB has nothing to disclose. PF has received lecture fees from Excemed and Biogen Idec and consulting fees from Biogen Idec and Novartis. UM-L has received lecture fees and travel grants from Almirall, Bayer, Biogen Idec, Genzyme, Merck Serono, Novartis, Boehringer Ingelheim, Sanofi, and Teva. KV has received lecture fees, travel grants, and fees for consulting from Bayer Schering, Biogen Idec, Genzyme, Merck Serono, Novartis, and Teva. SGM has received honoraria for lecturing and travel expenses for attending meetings and has received financial research support from Bayer, Bayer Schering, Biogen Idec, Genzyme, Merck Serono, MSD, Novartis, Novo Nordisk, Sanofi-Aventis, Teva, and UCB.

Figures

Figure 1
Figure 1
Electronic health (eHealth) technologies and health care. HCP: health care professional.
Figure 2
Figure 2
Overview of electronic health (eHealth) technologies applied in multiple sclerosis. CSI: Cognitive Stability Index; GEMS: Guidelines for Exercise in Multiple Sclerosis; HAT: Home Automated Telemanagement; MCCO: Mellen Center Care Online; MS: multiple sclerosis; MS-HAT: Multiple Sclerosis—specific version of Home Automated Telemanagement; MSDS3D: Multiple Sclerosis Documentation System: Three-Dimensional; MSPT: Multiple Sclerosis Performance Test; MSRS-R, Multiple Sclerosis Rating Scale-Revised; TaDiMuS: Tablet-based Data capture in Multiple Sclerosis; MAPSS-MS: Memory, Attention and Problem-Solving Skills for Persons with Multiple Sclerosis; ST: specific training; and tDCS: transcranial direct current stimulation.

References

    1. Khan F, Amatya B, Kesselring J, Galea M. Telerehabilitation for persons with multiple sclerosis. Cochrane Database Syst Rev. 2015 Apr 09;(4):CD010508. doi: 10.1002/14651858.CD010508.pub2. - DOI - PMC - PubMed
    1. Feys P, Giovannoni G, Dijsselbloem N, Centonze D, Eelen P, Lykke Andersen S. The importance of a multi-disciplinary perspective and patient activation programmes in MS management. Mult Scler. 2016 Aug;22(2 Suppl):34–46. doi: 10.1177/1352458516650741.22/2_suppl/34 - DOI - PubMed
    1. Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):61–6. doi: 10.1136/jnnp-2011-300616.jnnp-2011-300616 - DOI - PubMed
    1. Khan F, Amatya B, Kesselring J, Galea MP. Telerehabilitation for persons with multiple sclerosis. A Cochrane review. Eur J Phys Rehabil Med. 2015 Jun;51(3):311–25. http://www.minervamedica.it/index2.t?show=R33Y2015N03A0311 R33Y9999N00A150029 - PubMed
    1. Rasova K, Martinkova P, Pavlikoma M, Cattaneo D, Jonsdottir J, Henze T, Baert I, Van Asch P, Santovo C, Smedal T, Beiske AG, Stachowiak M, Kovalewski M, Nedeljkovic U, Bakalidou D, Alves-Guerreiro J, Nilsagård Y, Dimitrova EN, Habek M, Armutlu K, Donzé C, Ross E, Ilie AM, Martić A. Physical therapy provision in multiple sclerosis across Europe: a regional lottery? Eur J Phys Rehabil Med. 2015 Dec;51(6):850–2. http://www.minervamedica.it/index2.t?show=R33Y2015N06A0850 R33Y9999N00A150066 - PubMed